Skip to main content
NIH funding notice PAR-23-027

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Closed on October 17, 2023.

Posted
August 26, 2022
Close date
October 17, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $938,989 in first-year total cost, median $469,495.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 KUDS-F (54)]2

Most frequent institutions

  1. IOWA STATE UNIVERSITY1
  2. JOHNS HOPKINS UNIVERSITY1
Competing awards under PAR-23-027 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024MALDI Imaging of Acute Organophosphate Exposure in KIKO Mice1R01NS136102-01TRESSLER, CAITLINJOHNS HOPKINS UNIVERSITY, MD$479,989ZRG1
2024Mechanisms of Neurodegeneration in a Nerve Agent Model1R01NS133584-01A1THIPPESWAMY, THIMMASETTAPPAIOWA STATE UNIVERSITY, IA$459,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.